Method of treating systemic lupus erythematosus
T. A. Lisitsyna and colleagues · 2000 · RU2157684C2. Filed 22 December 1997; published 20 October 2000
What does this source report?
The patent describes four treatment groups using glucocorticoids with or without cyclophosphamide and Bemitil. It reports improvements in selected clinical and laboratory signs and anti-DNA antibodies in the Bemitil groups. This appears to describe the same research program as the 1999 paper.
- Population and setting
- 61 SLE patients treated at the Institute of Rheumatology, 1993–1997
- Evidence type
- Patent / reported experiments
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Patent reproduction; allocation concealment and blinding are not established. Treatment choice also reflected disease severity.
- Numerous outcomes and unequal follow-up periods prevent a simple comparative relapse-rate interpretation.
- Not an MS study or independent confirmation of the 1999 SLE report.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Russian patent reproduction
Review depth: Patent text reviewed
Related-report group: lisitsyna-sle-1993-1997. Reports in this group are not assumed to be independent trials.
Source access and review scope
Source text reviewed at the access level stated; no independent verification of patient data.
Recorded source-check date: 2026-10-03. This date does not imply a completed systematic review.
Cite and trace this record
Original source: T. A. Lisitsyna and colleagues. Method of treating systemic lupus erythematosus RU2157684C2. Filed 22 December 1997; published 20 October 2000 2000.
Molekul research summary: https://molekul.io/research/bemitil-sle-2000-patent. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry